September 30, 2024 by adminparwaz WHO: Using Injectable Lenacapavir as PreP to Prevent HIV Infection WHO praises the positive results of the PURPOSE-2 trial on long-acting injectable lenacapavir (LEN) for HIV prevention. An interim analysis revealed LEN’s high effectiveness in preventing HIV, with a 96%
